HP
Hikari Power Portfolio holdings
AUM
$1.2B
This Quarter Return
+1.39%
1 Year Return
+14.18%
3 Year Return
+56.59%
5 Year Return
+122.08%
10 Year Return
+191.59%
AUM
$1.02B
AUM Growth
+$1.02B
(-1.7%)
Cap. Flow
-$10.3M
Cap. Flow
% of AUM
-1.01%
Top 10 Holdings %
Top 10 Hldgs %
72.97%
Holding
65
New
1
Increased
3
Reduced
8
Closed
1
Top Buys
| 1 |
Elevance Health
ELV
|
$222K |
| 2 |
Waters Corp
WAT
|
$68.6K |
| 3 |
Brookfield
BN
|
$62.5K |
Top Sells
| 1 |
3M
MMM
|
$13.1M |
| 2 |
Novo Nordisk
NVO
|
$1.95M |
| 3 |
Wells Fargo
WFC
|
$1.94M |
| 4 |
Amgen
AMGN
|
$1.4M |
| 5 |
Wabtec
WAB
|
$319K |
Sector Composition
| 1 | Financials | 50.33% |
| 2 | Healthcare | 17.53% |
| 3 | Materials | 7.92% |
| 4 | Energy | 7.83% |
| 5 | Technology | 4.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Prudential Financial
PRU
$37.8B
| $603K | 0.06% |
6,350
| – | – |
|
52
IDEX
IEX
$12.1B
| $564K | 0.06% |
2,710
| – | – |
|
53
Anavex Life Sciences
AVXL
$817M
| $561K | 0.05% |
85,585
| – | – |
|
54
British American Tobacco
BTI
$120B
| $529K | 0.05% |
16,850
| – | – |
|
|
55
Brookfield
BN
$97.7B
| $469K | 0.05% |
15,000
+2,000
| +15% | +$62.5K |
|
56
Veeva Systems
VEEV
$44.4B
| $407K | 0.04% |
2,000
| – | – |
|
57
Vanguard High Dividend Yield ETF
VYM
$63.6B
| $251K | 0.02% |
2,430
| – | – |
|
|
58
Elevance Health
ELV
$72.4B
| $222K | 0.02% |
+510
| New | +$222K |
|
|
ALPN
59
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $142K | 0.01% |
12,445
| – | – |
|
60
Aldeyra Therapeutics
ALDX
$350M
| $134K | 0.01% |
20,020
| – | – |
|
61
Corvus Pharmaceuticals
CRVS
$419M
| $73K | 0.01% |
49,959
| – | – |
|
62
Ocular Therapeutix
OCUL
$2.25B
| $53K | 0.01% |
17,000
| – | – |
|
|
AKTX
63
Akari Therapeutics
AKTX
$21.4M
| – | – |
-6,541
| Closed | -$22K |
|